Showing results (111-120 of 177) with videos related to

Sort By:
Pageof 18
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2018
Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndromeEric Thouvenot, Geoffrey Hinsinger, Christophe Demattei, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
A randomized controlled phase II trial of riluzole in early multiple sclerosisEmmanuelle Waubant, Amir-Hadi Maghzi, Nisha Revirajan, et al.
Multiple Sclerosis and Related Disorders|April 21, 2015
Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosisAmir-Hadi Maghzi, Nisha Revirajan, Laura J Julian, et al.
Eclinicalmedicine|May 1, 2023
High-dose vitamin D3 supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trialSandra D Cassard, Kathryn C Fitzgerald, Peiqing Qian, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 20, 2019
Word-finding difficulty is a prevalent disease-related deficit in early multiple sclerosisRachel Brandstadter, Michelle Fabian, Victoria M Leavitt, et al.
Annals of Surgical Oncology|April 24, 2019
The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine TumorsAaron T Scott, Daniel Pelletier, Jessica E Maxwell, et al.
Annals of Clinical and Translational Neurology|May 5, 2021
Sleep disturbance and memory dysfunction in early multiple sclerosisJames F Sumowski, Sam Horng, Rachel Brandstadter, et al.
Neurology|April 27, 2018
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR studyAmit Bar-Or, Richard A Grove, Daren J Austin, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2008
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological eventJean-Christophe Corvol, Daniel Pelletier, Roland G Henry, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 16, 2022
Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosisJeffrey A Cohen, Fred D Lublin, Christoper Lock, et al.
Pageof 18